Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic

scientific article published on 01 January 2019

Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.1177/2324709619826167
P932PMC publication ID6350132
P698PubMed publication ID30791718

P2093author name stringDon C Rockey
Andrew D Schreiner
Amanda N Overstreet
Caroline Stokes Osborne
P2860cites workSelf-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)Q24616893
Drug-induced liver injury in obesityQ26828462
Nonalcoholic fatty liver disease: a systematic reviewQ28263139
Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseQ29614930
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infantQ34102747
Seizure and coma following Kratom (Mitragynina speciosa Korth) exposureQ34111502
Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa)Q34181061
Criteria of drug-induced liver disorders. Report of an international consensus meetingQ34271897
Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western CountriesQ34504233
Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.Q34535611
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkQ34943114
Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN).Q35009149
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment methodQ35644300
Drug-Induced Liver Injury: Pattern Recognition and Future DirectionsQ36412863
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conductQ36799781
Acute Cytomegalovirus Hepatitis in an Immunocompetent Host as a Reason for Upper Right Abdominal PainQ37057099
Overview of the diagnosis of cytomegalovirus infectionQ37062282
Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse PotentialQ42058872
Inhibitory effect of mitragynine on human cytochrome P450 enzyme activitiesQ42934962
Suspected Adulteration of Commercial Kratom Products with 7-HydroxymitragynineQ45759119
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver diseaseQ50117379
Legal highs on the Internet.Q52295945
Drug induced liver injury with analysis of alternative causes as confounding variables.Q54243795
Kratom: a dangerous player in the opioid crisis.Q55399670
Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallengeQ72576810
Cholestatic hepatitis from prolonged kratom use: a case reportQ86042400
P921main subjectopioidQ427523
P304page(s)2324709619826167
P577publication date2019-01-01
P1433published inJournal of investigative medicine high impact case reportsQ27725587
P1476titleDrug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic
P478volume7

Reverse relations

Q90115925Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literaturecites workP2860

Search more.